Terms: = Prostate cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Diagnosis
51 results:
1. [Levels of tPSA and fPSA and count of peripheral blood neutrophils in the diagnosis of prostate cancer].
Zhang SQ; Su Q
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1089-1095. PubMed ID: 37846628
[TBL] [Abstract] [Full Text] [Related]
2. Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring.
Luo X; Zhang L; Cui J; An Q; Li H; Zhang Z; Sun G; Huang W; Li Y; Li C; Jia W; Zou L; Zhao G; Xiao F
Clin Transl Med; 2023 Sep; 13(9):e1393. PubMed ID: 37649244
[TBL] [Abstract] [Full Text] [Related]
3. Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells.
Wang Z; Li Y; Zhao W; Jiang S; Huang Y; Hou J; Zhang X; Zhai Z; Yang C; Wang J; Zhu J; Pan J; Jiang W; Li Z; Ye M; Tan M; Jiang H; Dang Y
Signal Transduct Target Ther; 2023 May; 8(1):175. PubMed ID: 37121942
[TBL] [Abstract] [Full Text] [Related]
4. Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study.
Moraes FY; Gouveia AG; Lima RP; Bratti VF; Hamamura AC; Viani GA
J Cancer Policy; 2023 Jun; 36():100367. PubMed ID: 36216270
[TBL] [Abstract] [Full Text] [Related]
5. First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the prostate cancer Registry.
Galli L; Chiuri VE; Di Lorenzo G; Pisconti S; Rossetti S; Sirotova Z; Muto A; Petrioli R; De Tursi M; Sbrana A; Francolini G; Ardizzoia A; Scavelli C; Satta F; Quadrini S; Airoldi M; D'Aniello C; Bonetti A; Conforti S; Aieta M; Beccaglia P; Maestri A; Fratino L
Tumori; 2023 Apr; 109(2):224-232. PubMed ID: 35400269
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: Histological features for accurate diagnosis and toward future novel therapies.
Ida A; Okubo Y; Kasajima R; Washimi K; Sato S; Yoshioka E; Osaka K; Suzuki T; Yamamoto Y; Yokose T; Kishida T; Miyagi Y
Pathol Res Pract; 2022 Jan; 229():153731. PubMed ID: 34952423
[TBL] [Abstract] [Full Text] [Related]
7. Higher serum alkaline phosphatase value indicates the need for bone mineral density testing in non-metastatic prostate cancer patients undergoing androgen deprivation therapy.
Hagiwara K; Sakamoto A; Sasaki K; Kanatani A; Kimura M; Kaneko T; Takahashi S; Yamada Y; Nakagawa T
Jpn J Clin Oncol; 2022 Jan; 52(1):73-80. PubMed ID: 34542155
[TBL] [Abstract] [Full Text] [Related]
8. prostate-specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study).
Inoue T; Yoshimura K; Terada N; Tsukino H; Murota T; Kinoshita H; Kamoto T; Ogawa O; Matsuda T
Int J Urol; 2021 Aug; 28(8):849-854. PubMed ID: 34008275
[TBL] [Abstract] [Full Text] [Related]
9. Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment.
Wong SK; Hamm J; Shokoohi A; McGahan CE; Ho C
BMC Cancer; 2021 Mar; 21(1):215. PubMed ID: 33653306
[TBL] [Abstract] [Full Text] [Related]
10. Optimized MRI Assessment for Clinically Significant prostate cancer: A STARD-Compliant Two-Center Study.
Bao J; Zhi R; Hou Y; Zhang J; Wu CJ; Wang XM; Zhang YD
J Magn Reson Imaging; 2021 Apr; 53(4):1210-1219. PubMed ID: 33075177
[TBL] [Abstract] [Full Text] [Related]
11. A Rare Case of Inflammatory Myofibroblastic Tumor of the prostate and Review of the Literature.
Kim MS; Lim SC
In Vivo; 2020; 34(4):2043-2048. PubMed ID: 32606180
[TBL] [Abstract] [Full Text] [Related]
12. Temporal Trends and Practice Patterns for Inpatient Management of Malignant Extrinsic Ureteral Obstruction in the United States.
Haas CR; Shah O; Hyams ES
J Endourol; 2020 Aug; 34(8):828-835. PubMed ID: 32340482
[No Abstract] [Full Text] [Related]
13. [Palmitoylome profiling indicates that androgens promote the palmitoylation of metabolism-related proteins in prostate cancer-derived LNCaP cells].
Li WQ; Ren SM; Long XB; Tian YQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 52(2):227-233. PubMed ID: 32306003
[TBL] [Abstract] [Full Text] [Related]
14. Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study.
Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
BMJ Open; 2019 Dec; 9(12):e033944. PubMed ID: 31874896
[TBL] [Abstract] [Full Text] [Related]
15. Feasibility of integrating computer-aided diagnosis with structured reports of prostate multiparametric MRI.
Zhu L; Gao G; Liu Y; Han C; Liu J; Zhang X; Wang X
Clin Imaging; 2020 Mar; 60(1):123-130. PubMed ID: 31874336
[TBL] [Abstract] [Full Text] [Related]
16. Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches - a single center preliminary study.
Huang GL; Kang CH; Lee WC; Chiang PH
BMC Urol; 2019 Oct; 19(1):101. PubMed ID: 31660936
[TBL] [Abstract] [Full Text] [Related]
17. Role of transvaginal ultrasound-guided biopsy in gynecology.
Mascilini F; Quagliozzi L; Moro F; Moruzzi MC; De Blasis I; Paris V; Scambia G; Fagotti A; Testa AC
Int J Gynecol Cancer; 2020 Jan; 30(1):128-132. PubMed ID: 31645428
[TBL] [Abstract] [Full Text] [Related]
18. Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
Liu YR; Hu Y; Zeng Y; Li ZX; Zhang HB; Deng JL; Wang G
J Cell Biochem; 2019 Oct; 120(10):18041-18052. PubMed ID: 31297877
[TBL] [Abstract] [Full Text] [Related]
19. Vasectomy and prostate cancer Risk: A 38-Year Nationwide Cohort Study.
Husby A; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2020 Jan; 112(1):71-77. PubMed ID: 31119294
[TBL] [Abstract] [Full Text] [Related]
20. Cost-Effectiveness of Active Surveillance, Radical prostatectomy and External Beam Radiotherapy for Localized prostate cancer: An Analysis of the ProtecT Trial.
Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
[TBL] [Abstract] [Full Text] [Related]
[Next]
